Reports that tumor-associated carbohydrate antigens are prime candidates for cancer vaccines because of their involvement in metastasis and the rapid growth of tumors. Effect of the inability of the antigens to elicit a T-cell dependent immune response on immunogens; Reduction of tumor growth through vaccination of mice with the peptide mimotype.